CD8A and neoplasm: For example, after inhibiting the PI3Kγ pathway, Copanlisib increases the infiltration of CD8+ T cells in the tumor microenvironment, reduces Treg cells, and elevates levels of pro-inflammatory cytokines such as IFN-γ (88, 89).